维普中文期刊产品整合服务
6篇 您的检索式:作者名="G.L.Spaeth"
    题名 作者 年代 出处 被引量
1THE PRESSURE LOWERING EFFECTS OF BIMATOPROST ONCE DAILY AT BED-TIME IN PATIENTS WHO FAILED PREVI-OUS LATANOPROST TREATMENT显示文摘Purpose: To evaluate the pressure lowering effects of bimato-prost once daily at bedtime in patients who failed previous la- tanoprost treatment. Methods: This was a prospective case series of patients who did not achieve intraocular pressure (IOP) reduction of 15% with latanoprost, recruited to receiveL.Magacho L.J.Katz W.C.Steinmann J.S.Myers G.L.Spaeth D.Rhee R.L.Wilson M.Moster 2003国际眼科杂志2003,3,1:0
2THE DISC DAMAGE LIKELIHOOD SCORE A USEABLE TOOL IN THE DIAGNOSIS AND MANAGEMENT OF GLAUCOMA显示文摘Purpose: To discuss the value of a new method of grading quantitatively the amount of disc damage in patients with glaucoma Methods: The Disc Damage Likelihood Score (DDLS) employs 9 stages of damage based on the width of the neuroretinal rim or the circumferential extent of absence of rim, adjusted for the size of the optic disc. We report the results of studies regarding re-G.L.Spaeth J.D.Henderer A.Bayer 2003国际眼科杂志2003,3,1:0
3RELEASABLE SUTURES IMPROVE THE OUTCOME OF TRABECULECTOMY显示文摘Purpose: To evaluate and demonstrate the advantages and disadvantages of releasable sutures to close the scleral flap in the performance of a guarded filtration procedure. Methods: Retrospective chart review of 100 cases of guarded filtration procedure employing releasable sutures, and presentation of a video demonstrating the technique of placing releasable suture. Re-G.L.Spaeth L.J.Katz M.Makar R.Shetty 2003国际眼科杂志2003,3,1:0
4A NEW METHOD OF UTILIZING 5-FLUO- ROURACIL POSTOPERATIVELY THAT DECREASES CORNEAL COMPLICATIONS显示文摘Purpose: To test a new method of applying 5-Fluo-rouracil (5-FU) postoperatively developed by author Khaw. Methods: Observational series of 17 cases having guarded filtration procedure. 5-FU was administered postperatively as follows: The eye was anesthetized topically. A 30-gauge needle on a vial of Healon GV was introduced into the inferotemporal conjunctiva 5mm inferior to the limbus, and a bolus of 0.2 mL ofG.L.Spaeth P.T.Khaw 2003国际眼科杂志2003,3,1:0
5TRENDS IN GLAUCOMA MANAGEMENT显示文摘Glaucomatous disease is loss of function and deterioration in quality of life due to pain and/or loss of ganglion cells caused at last partly by intraocular pressure higher than the tissues of the eye can tolerate. Treatment is designed to prevent the disease. Treatment does that by preventing pain and loss of ganglion cells. Unless it is probable that the patient will be in someG.L.Spaeth 2003国际眼科杂志2003,3,1:0
6THE TIGR/MYOC MT.1 VARIANT ACCEL- ERATES DISEASE PROGRESSION IN POAG PATIENTS: EFFECTS ON OPTIC DISC AND VISUAL FIELD MEASURES OF DAMAGE显示文摘The myocilin mt. 1 genotype (TIGR/MYOC mt.1, -1000 C/G) found in approximately 15% of subjects was evaluated for its potential effects on disease progression in patients that were followed at the Wills Eye Hospital glaucoma clinic. 147 POAG patients over 35 years of age with an average follow-up of approximately 15 years were studied. Optic disc and visual fieldJ.R.Polansky G.L.Spaeth R.P.Juster 2003国际眼科杂志2003,3,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费